Protaryx Medical Announces $8.3M in Funding for First-in-Class Technology for Left Atrial Access in Transcatheter Cardiac Procedures
Retrieved on:
Tuesday, June 30, 2020
Protaryx Medical, a company committed to reimagining access to the left atrium for transcatheter cardiac procedures, today announced that it has raised $8.3 million in funding to develop the companys first-in-class device for precision transseptal access to the left atrium during structural heart and catheter ablation procedures.
Key Points:
- Protaryx Medical, a company committed to reimagining access to the left atrium for transcatheter cardiac procedures, today announced that it has raised $8.3 million in funding to develop the companys first-in-class device for precision transseptal access to the left atrium during structural heart and catheter ablation procedures.
- Were pleased to partner with the experienced team at Ajax Health to leverage its proven expertise and reputation for supporting successful emerging medical device companies.
- The innovative Protaryx device is designed with the goal of simplifying transseptal access for physicians, which may lead to fewer complications and improved outcomes for patients.
- Protaryx Medical is a medical device company committed to reimagining access to the left atrium for transcatheter cardiac procedures.